ClinicalTrials.Veeva

Menu

Alveolar Dead Space as Predictor of Organ Failure in Severe Sepsis

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Begins enrollment in 9 months

Conditions

Multi-organ Failure
Severe Sepsis
Septic Shock
Sepsis

Study type

Observational

Funder types

Other

Identifiers

NCT01315782
HSC-MS-10-0555

Details and patient eligibility

About

This is an observational study to understand the changes in alveolar dead space in medical critically ill patients with severe infection (severe sepsis) requiring mechanical ventilation and the possibility to predict multi-organ failure.

The measurement of alveolar dead space used to require sophisticated equipment and time. New ventilators have microprocessors that allow rapid mathematical calculation with minimal intervention.

Full description

The patient will be followed during their ICU stay up to two weeks while on mechanical ventilation.

Patient will be followed daily for the initial 48 hours and then once per week for 2 weeks while mechanically ventilated.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults with severe sepsis or septic shock on mechanical ventilation
  • Enrolled in the initial six hours of ICU admission

Exclusion criteria

  • Patients with withdrawal or hospice order.
  • Patients with terminal, irreversible disease, expect to decease in 48 hours from ICU admission.
  • Patients with COPD.
  • Patients transferred from outside ICU with ongoing sepsis management for more than six hours.

Trial design

30 participants in 1 patient group

Multi-organ failure
Description:
Alveolar dead space on mechanically ventilated patients with severe sepsis or septic shock.

Trial contacts and locations

1

Loading...

Central trial contact

Rosa M Estrada-Y-Martin, MD MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems